Drug Type Bispecific antibody |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Biomunex Pharmaceuticals SASStartup |
Active Organization Biomunex Pharmaceuticals SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | FR | Biomunex Pharmaceuticals SASStartup | - |
Pancreatic Carcinoma | Discovery | FR | Biomunex Pharmaceuticals SASStartup | - |